Eyeonix AIQ to Pay 30.6M Shares for COMMAND HEALGRID Source Code
EAIQ filed a M&A and Partnerships on light trading volume (0.1× avg).
Summary
Eyeonix AIQ's subsidiary signed an MOU to buy the COMMAND HEALGRID source code from Greece-based Eyeonix S.A. for 30.6 million shares, with closing expected this calendar year.
Key Events · M&A and Partnerships · EAIQ
-
MOU to Acquire COMMAND HEALGRID Source Code
On October 30, 2026, wholly owned subsidiary Eyeonix MedAIQ, Inc. signed a Memorandum of Understanding with Eyeonix S.A. of Greece to acquire all rights to the COMMAND HEALGRID software source code, with MedAIQ assuming ongoing development.
-
Consideration Is 30.6 Million Shares
The entire purchase price is 30,600,000 shares of Eyeonix AIQ common stock issued to Eyeonix Greece — no cash component disclosed. The filing does not state shares outstanding, so the dilution percentage cannot be calculated from this document.
-
Related-Party Counterparty
The seller, Eyeonix S.A., shares the Eyeonix name with the issuer and its subsidiary, indicating an affiliated transaction; the filing discloses no independent valuation or fairness opinion for the asset.
-
Closing Targeted This Calendar Year
The MOU is non-binding and the transaction is expected to finalize in calendar 2026; no specific closing date, conditions, or termination terms were disclosed.
Analysis · EAIQ · Trade & Services
Eyeonix AIQ's wholly owned subsidiary has signed a non-binding MOU to acquire the COMMAND HEALGRID source code from Eyeonix S.A., a Greek company, paying entirely in 30.6 million newly issued shares rather than cash. The share count is the whole story: the company has not disclosed its outstanding share count in this filing, so the dilution cannot be quantified here, but 30.6 million shares is a large absolute block for a $1.98 stock and the counterparty shares the Eyeonix name, making this a related-party deal that warrants scrutiny of the terms. The MOU is not a closed transaction — it is expected to finalize this calendar year, and no valuation, revenue, or asset financials were provided, so investors are being asked to accept a share-funded purchase of an unspecified-value asset on trust.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EAIQ was trading at $1.98 on OTC in the Trade & Services sector. The 52-week trading range was $0.01 to $3.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.